MAPT and Alzheimer disease: Recently, studies using mice and neurons devoid of tau suggest that partial reduction of overall tau levels could effectively protect neurons against Aβ and excitotoxicity3, 4, 5, 6, 35, demonstrating that fisetin-mediated decrease in total tau level might be beneficial for AD patients.